118 results
Keyword Triumeq Remove keyword
-
List item
Opinion/decision on a Paediatric investigation plan (PIP): Triumeq, dolutegravir, abacavir, lamivudine
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: EMEA-001219-PIP01-11-M05, Route(s) of administration: Oral use, Pharmaceutical form(s): Film-coated tablet, Dispersible tablet
Decision date: 17/03/2021, Last updated: 23/11/2021, Compliance check: XInvented name Triumeq Active substance dolutegravir … abacavir / lamivudine (Triumeq), (EMEA-001219-PIP01-11-M05 … abacavir / lamivudine (Triumeq), (EMEA-001219-PIP01-11-M05 … -
List item
Human medicine European public assessment report (EPAR): Triumeq (updated)
dolutegravir sodium, lamivudine, abacavir (as sulfate), HIV Infections
Date of authorisation: 31/08/2014, Revision: 32, Authorised, Last updated: 27/11/2023Triumeq Blood-Borne Infections Communicable … sodium / lamivudine Overview Triumeq is a medicine for treating … who weigh at least 14 kg. Triumeq contains three The substance … -
List item
Press release: New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir
PRAC, Last updated: 18/05/2018lamivudine and abacavir as Triumeq. Further information on these … lamivudine and abacavir as Triumeq. Further information on these … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 June 2014
Last updated: 27/06/2014Triumeq … -
List item
Press release: Updated advice on body fat changes and lactic acidosis with HIV medicines
CHMP, Last updated: 23/10/2015Stribild, Sustiva, Telzir, Triumeq, Trizivir, Truvada, Viramune … Lamivudine ViiV, Stribild, Triumeq, Truvada, Viread and Ziagen … Stribild, Sustiva, Telzir, Triumeq, Trizivir, Truvada, Viramune … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022
CHMP, Last updated: 16/12/2022Triumeq … -
List item
Human medicine European public assessment report (EPAR): Trizivir (updated)
abacavir (as sulfate), lamivudine, zidovudine, HIV Infections
Date of authorisation: 27/12/2000, Revision: 43, Authorised, Last updated: 29/11/2023regimen. (e.g. Kivexa, Ziagen, Triumeq) • Trizivir must be stopped … abacavir (e.g. Kivexa, Ziagen, Triumeq) must never be re- initiated … -
List item
Human medicine European public assessment report (EPAR): Kivexa (updated)
abacavir, lamivudine, HIV Infections
Date of authorisation: 16/12/2004, Revision: 37, Authorised, Last updated: 27/11/2023 -
List item
Human medicine European public assessment report (EPAR): Ziagen
abacavir, HIV Infections
Date of authorisation: 08/07/1999, Revision: 47, Authorised, Last updated: 28/09/2023 -
List item
Human medicine European public assessment report (EPAR): Dovato
dolutegravir sodium, lamivudine, HIV Infections
Date of authorisation: 10/06/2022, Revision: 14, Authorised, Last updated: 12/09/2023 -
List item
Human medicine European public assessment report (EPAR): Tivicay
dolutegravir, HIV Infections
Date of authorisation: 16/01/2014, Revision: 34, Authorised, Last updated: 14/08/2023 -
List item
Human medicine European public assessment report (EPAR): Adempas
riociguat, Hypertension, Pulmonary
Date of authorisation: 27/03/2014, Revision: 13, Authorised, Last updated: 31/08/2023 -
List item
Human medicine European public assessment report (EPAR): Rekambys
rilpivirine, HIV Infections
Date of authorisation: 17/12/2020,
, Revision: 9, Authorised, Last updated: 13/10/2023
-
List item
Human medicine European public assessment report (EPAR): Juluca
dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018, Revision: 14, Authorised, Last updated: 02/02/2023 -
List item
Human medicine European public assessment report (EPAR): Combivir
lamivudine, zidovudine, HIV Infections
Date of authorisation: 18/03/1998, Revision: 37, Authorised, Last updated: 29/08/2022 -
List item
Human medicine European public assessment report (EPAR): Epivir
lamivudine, HIV Infections
Date of authorisation: 08/08/1996, Revision: 50, Authorised, Last updated: 29/08/2022 -
List item
Human medicine European public assessment report (EPAR): Vocabria
Cabotegavir sodium, Cabotegravir, HIV Infections
Date of authorisation: 17/12/2020,, Revision: 8, Authorised, Last updated: 12/01/2023
-
List item
Human medicine European public assessment report (EPAR): Genvoya
elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide, HIV Infections
Date of authorisation: 19/11/2015, Revision: 27, Authorised, Last updated: 28/11/2022 -
List item
Opinion on medicine for use outside EU: Lamivudine ViiV
lamivudine, HIV Infections, ATC code: J05AF05 Opinion number: H/W/673, Withdrawn opinion Opinion date: 17/11/2005, Last updated: 05/07/2018 -
List item
Opinion on medicine for use outside EU: Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK)
lamivudine, zidovudine, HIV Infections, ATC code: J05AR01 Opinion number: H/W/672, Withdrawn opinion Opinion date: 17/11/2005, Last updated: 05/07/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28-31 August 2023
European Medicines Agency, Amsterdam, the Netherlands, from 28/08/2023 to 31/08/2023, Last updated: 27/10/2023 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 04/12/2023 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 10/11/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-26 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 24/04/2023 to 26/04/2023, Last updated: 07/07/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 06/02/2023 to 09/02/2023, Last updated: 17/05/2023